000			01757ngm a2200385 a 4500
001			HST7151
003			UkLoHST
006			m c
007			cr|cna|||a||||
007			vz|czazum
008			190904s2019 enk|||||||||||s|||v|eng d
028	5	0	_a7151 _bHenry Stewart Talks
035			_a(UkLoHST)4034
040			_aUkLoHST _beng _cUkLoHST
100	1		_aClemen, Robert T. _q(Robert Taylor), _d1952- _4spk
245	1	0	_aUsing decision analysis to optimise R&D investment _h[electronic resource] : _bthe case of SmithKline Beecham / _cRobert Clemen.
260			_aLondon : _bHenry Stewart Talks, _c2019.
300			_a1 online resource (1 streaming video file (7 min.) : _bcolor, sound).
490	1		_aThe business & management collection, _x2056-4570
500			_aAnimated audio-visual presentation with synchronized narration.
500			_aBite-size case study extracted from the talk: Decision analysis.
500			_aTitle from title frames.
506			_aAccess restricted to subscribers.
520			_aThis case study examines SmithKline Beecham's use of decision analysis to determine which R&D projects to fund. This process significantly improved on the "project champion" approach, resulting in a substantial increase in value for the same amount of capital investment.
538			_aMode of access: World Wide Web.
610	2	0	_aSmithKline Beecham Pharmaceuticals _xManagement.
650		0	_aDecision making _vCase studies.
650		0	_aDrugs _xResearch.
650		0	_aPharmaceutical industry _xManagement.
650		0	_aResearch _xFinance.
650		0	_aResource allocation.
740	0		_aDecision analysis.
830		0	_aHenry Stewart talks. _pBusiness & management collection.
856	4	0	_uhttps://hstalks.com/bm/4034/
999			_c79113 _d79113